Quotables
"One of the greatest labor saving inventions of today is tomorrow!"
Vincent T. Floss
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7956187 | Method for decreasing opioid metabolism 8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is —CH2OH, —CH2NH2, —NHSO2CH3, Q is O or S and Y is O, S or NOH are useful as analgesic... | 06/07/2011 |
| 7928236 | Fluorescent amino acid derivatives The subject of the present invention is to provide a fluorescent substance excitable under visible light, having higher photostability and a long fluorescence lifetime. Another subject is to provide a fluorescent substance consists of a non-natural amino acid applic... | 04/19/2011 |
| 7795435 | Process for obtaining the polymorphic form I of finasteride The process includes the steps of (i) dissolving finasteride in a substantially anhydrous organic solvent selected among n-butyl acetate, iso-butyl acetate, sec-butyl acetate, tert-butyl acetate, C5 alkyl acetate and mixtures thereof, at a temperature equ... | 09/14/2010 |
| 7737278 | Colorant compounds Compounds of the formula wherein R1, R2, R3, R4, R5, R6, R66, m, n, p, and G are as defined herein. ... | 06/15/2010 |
| 7674905 | Fluoroquinolonoquinolones and inkjet ink compositions comprising the same The present invention relates to modified yellow pigments comprising yellow pigments having attached at least one organic group. The yellow pigment is a fluoroquinolonoquinolone pigment. Also disclosed are inkjet ink compositions comprising these modified yellow pig... | 03/09/2010 |
| 7622580 | Colorant compounds Compounds of the formula wherein R1, R2, R3, R4, R5, R6, R66, m, n, p, and G are as defined herein. ... | 11/24/2009 |
| 7495100 | Synthesis of indenoisoquinolines Indenoisoquinolines and dihydroindenoisoquinolines are described. In particular, such compounds possessing one or more electron withdrawing substituents are described. The in vitro anticancer activities of these molecules tested in the National Cancer Institute's sc... | 02/24/2009 |
| 7393955 | Isoquinoline derivatives and methods of use thereof The invention provides novel classes of Isoquinoline Derivatives. Pharmaceutical compositions and methods of making and using the compounds, are also described. ... | 07/01/2008 |
| 7381722 | Tetracyclic amino and carboxamido compounds and methods of use thereof The present invention relates to Tetracyclic Amino Compounds and Tetracyclic Carboxamido Compounds, compositions comprising an effective amount of a Tetracyclic Amino Compound or a Tetracyclic Carboxamido Compound and methods for treating or preventing an inflammato... | 06/03/2008 |
| 7326696 | Amino-methyl substituted tetracycline compounds Aminomethyl substituted tetracycline compounds, pharmaceutical compositions, and methods of use thereof are discussed. ... | 02/05/2008 |
| 7312228 | Cytotoxic indeno and isoindoloisoquinolones The synthesis and biological activity of benzoisoindoloisoquinolone compounds are described. The synthesis and biological activity of C-11-substituted indenoisoquinolones are also described. Indenoisoquinolones substituted at C-11 are prepared by McMurry reactions o... | 12/25/2007 |
| 7256292 | Fluorescent dye compounds, conjugates and uses thereof The present teachings generally relate to fluorescent dyes, linkable forms of fluorescent dyes, energy transfer dyes, reagents labeled with fluorescent dyes and uses thereof. ... | 08/14/2007 |
| 7220754 | Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists Mono-ester and asymmetrically substituted diesters of dihydrexidine, dinapsoline and A-86929 and substituted derivatives thereof are described. The novel ester/diester derivatives exhibit improved pharmacokinetic characteristics relative to their unesterified parent... | 05/22/2007 |
| 7217709 | Tetracyclic benzamide derivatives and methods of use thereof The invention relates to Tetracyclic Benzamide Derivatives; compositions comprising a Tetracyclic Benzamide Derivative; and methods for treating or preventing an inflammatory disease, a reperfusion disease, an ischemic condition, renal failure, diabetes, a diabetic ... | 05/15/2007 |
| 7208492 | Topoisomerase-targeting agents The invention provides compounds of formula I or formula II: wherein: the bond represented by --- is a single bond or a double bond, and R1–R5, X, and Y have any of the meanin... | 04/24/2007 |
| 7186838 | Fluorinated 4-azasteroid derivatives as androgen receptor modulators Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner. They are useful as agonists of the androgen receptor in bone and/or muscle tissue while antagonizing the AR in the prostate of a male patient or in the uteru... | 03/06/2007 |
| 7169922 | Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings The present invention describes novel dyes, including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings. The dyes of the invention absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic r... | 01/30/2007 |
| 7164022 | Process for the preparation of pure Finasteride The present invention relates to an improved process for the preparation of pure Finasteride of Formula I, which comprises converting dihydrofinasteride to finasteride through novel protected dihydrofinasteride a... | 01/16/2007 |
| 7091212 | Chiral dinapsoline The present invention relates to the preparation of the optical isomer (R)-(+)-8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-napth[1,2,3-de]isoquinoline. This invention also relates to the use of pharmaceutical compositions comprising (R)-(+)-8,9-dihydroxy-2,3,7,11b-tetrahy... | 08/15/2006 |
| 7084274 | Method for the selective preparation of 3-oxo-4-aza-5α-androstane compound This invention relates to a method for selectively preparing the 3-oxo-4-aza-5¥á-androstane compound which is used as an intermediate of finasteride by heating 3-oxo-4-aza-5-androstene in a mixture of formic acid and an alkanediol in the presence of zinc. ... | 08/01/2006 |
| 7049374 | Heterodiamondoids This invention is related to heteroatom containing diamondoids (i.e., “heterodiamondoids”) which are compounds having a diamondoid nucleus in which one or more of the diamondoid nucleus carbons has been substitutionally replaced with a noncarbon atom. These hete... | 05/23/2006 |
| 7041354 | Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with one or more reflection layers and to whose surface a light-writeable information layer, if desired one or more reflection layers and if desired... | 05/09/2006 |
| 7038050 | Method for the preparation of highly pure 1-androstene derivatives A method for preparing a 1-androstene derivative which comprises reacting a 2-iodo-androstane derivative with an oxidizing agent while maintaining the pH of the reaction mixture at a specific range gives the 1-androstene derivative with high purity and yield. ... | 05/02/2006 |
| 7022854 | Forms of dutasteride and methods for preparation thereof A crystalline Form II of 17β-N-[2,5-bis (trifluoromethyl)phenyl]carbamoyl-4-aza-5-α-androst-1-en-3-one (dutasteride) is provided. The preferred crystalline Form II of dutasteride has an X-ray powder diffraction pattern, expressed in terms of d-spacing (in ° A), w... | 04/04/2006 |
| 7015327 | Anthrapyridone compounds, water-base magenta ink compositions and method of ink-jet recording New anthrapyridone compounds represented by the general formula (14): {wherein R represents a hydrogen atom, an alkyl group (optionally substituted with mono- or di-alkylamino group), a lower alkyl group (optionally subst... | 03/21/2006 |
| 7011701 | Dye and ink jet printing ink A dye is disclosed, which is represented by the following formula: wherein Z is an atomic group necessary to form a 6-membered nitrogen containing aromatic ring; R11 is a hydrogen bonding group; R12 | 03/14/2006 |
| 6992088 | Nitro and amino substituted heterocycles as topoisomerase I targeting agents The invention provides compounds of formula I: wherein: R1-R5, “a” and X have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also p... | 01/31/2006 |
| 6956035 | Isoquinoline derivatives and methods of use thereof The invention provides novel classes of Isoquinoline Derivatives. Pharmaceutical compositions and methods of making and using the compounds, are also described. ... | 10/18/2005 |
| 6953854 | Process for preparing crystalline Form I of cabergoline A process for producing crystalline form I of cabergoline, which process comprises crystallization of the desired form from a toluene/diethyl ether mixture comprising raw cabergoline, followed by recovery and drying of the resulting crystals. A new solvate form V of... | 10/11/2005 |
| 6949647 | Synthesis of pancratistatin (+)-Narciclasine (2), available in quantity from certain Amaryllidaceae species or by total synthesis, is employed in for a ten step synthetic conversion (3.6% overall yield) to natural (+)-pancratistatin (1a). The key procedures involve the epoxidation of na... | 09/27/2005 |
| 6949561 | Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase A sulphamate compound suitable for use as an inhibitor of oestrone sulphatese (E.C.3.1.6.2) is described. The compound is a polycyclic compound comprising at least two ring components, wherein the polycyclic compound comprises at least one sulphamate group attached ... | 09/27/2005 |
| 6828319 | Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof The invention provides novel classes of substituted Indeno[1,2-c]isoquinoline Compounds. Pharmaceutical compositions and methods of making and using the compounds, are also described. ... | 12/07/2004 |
| 6825208 | Tetrahydroquinoline derivatives as antithrombotic agents This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions c... | 11/30/2004 |
| 6818635 | 7-substituted tetracycline compounds The present invention pertains, at least in part, to novel 7-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known ap... | 11/16/2004 |
| 6800634 | Modulators of Rho C activity Compounds of formula 1 modulate the activity of Rho C: wherein R1 is H, OH, or lower alkyl; R2, R3, R4, R5, and R6 are each independently H, halo, ... | 10/05/2004 |
| 6794508 | Process An improved process for preparing steriods, such as 3-oxo-4-azasteroids, is described. Compounds of this type are known to be useful in the preparation of compounds having 5a-reductase inhibitor activity. The process comprises the hydrogenation of the corresponding ... | 09/21/2004 |
| 6770760 | Nucleic acid bulge-detecting agent This invention relates to a metal complex of formula (I). The metal complex is capable of cleaving a bulge-containing nucleic acid at the bulge site with high specificity. ... | 08/03/2004 |
| 6762302 | Process for dehydrogenation of azaandrostane compounds The invention relates to a process for the production of compounds of general formula (I), wherein R1 is a —NH-tert-butyl group or a 4-methyl-piperidino group, by bioconversion of compounds of general formula (II), wherein R1 is as described ... | 07/13/2004 |
| 6747038 | Phenanthridine derivatives and antitumoral medicaments containing phenanthridine The invention relates to novel phenanthridine derivatives and to medicaments, which are for use in antitumoral therapy and prophylaxis and which contain these phenanthridine derivatives. It could be shown that up to now specifically substituted phenanthridine deriva... | 06/08/2004 |
| 6727363 | Process for preparing crystalline form I of cabergoline A process for producing crystalline form I of cabergoline, which process comprises crystallization of the desired form from a toluene/diethyl ether mixture comprising raw cabergoline, followed by recovery and drying of the resulting crystals. A new solvate form V of... | 04/27/2004 |
